Prof. Ferrer obtained his PhD in Chemistry in 1989 (Univ. Alicante). Between 1989-1997 he was a researcher in the Depts of Physics and Biology at University of California at San Diego (UCSD) investigating the role of ion channels in human diseases. In 1998, he joined the Miguel Hernández University (UMH) as an associate professor, in 2005 was accredited to full professor, appointed deputy director of the Institute of Molecular and Cellular Biology (IBMC), and in 2011 director. Since 2018, he is the director of the Institute in Healthcare Biotechnology (IDiBE) at the UMH. His research is focused on the field of peripheral neuropathies with the aim of understanding the pathophysiological underlying mechanisms of chronic pain. A major goal has been to develop pre-clinical disease models and disease-modifying non-immunosuppressant therapeutics that reduce the disabling neuropathic symptoms and contribute to resolve the pathological state to physiology. He has published 160+ papers (80% in Q1), led 23 R&D projects as PI, registered 30+ patent applications (75 licensed and under exploitation), given 100+ conferences, and mentored 26 doctoral theses. He has fostered the clinical development of 3 drug candidates and promoted the foundation of 5 biotech companies (spin-off). He has been a member of the executive councils of the Spanish societies of biophysics (SBE) and biochemistry and molecular biology (SEBBM), president of the SBE (2014-2018), president-elect of the SEBBM, and  currently its president (2024-2028). In the period 2018-2022, he has been the Spanish representative in the IUPAB, and since 2023 in FEBS. In 2020, he became the editor-chief of the SEBBM magazine. He is the coordinator of the Spanish network in ion channels since 2008 (RECI, www.reci-ionchannel.es). In the period 2016-2021, he was the national manager of the R&D area entitled Development of Diagnostic, Prognostic and Therapeutic Tools of the Biomedicine R&D program at the State Agency of Research of the Ministry of Science and Innovation. He has received the Beckman-Coulter Award (SEBBM, 2002); Alberto Sols best work (Sax, 2002), Grünenthal Foundation (2002), Esteve Foundation (2005), Bruker (SBE, 2012), Alberto Sols best research career (2020).